See more : DeNA Co., Ltd. (2432.T) Income Statement Analysis – Financial Results
Complete financial analysis of I’rom Group Co., Ltd. (2372.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of I’rom Group Co., Ltd., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Willis Towers Watson Public Limited Company (0Y4Q.L) Income Statement Analysis – Financial Results
- Southside Bancshares, Inc. (SBSI) Income Statement Analysis – Financial Results
- CrowdFundMe S.p.A. (CFM.MI) Income Statement Analysis – Financial Results
- Winmill & Co. Incorporated (WNMLA) Income Statement Analysis – Financial Results
- Guangzhou Sanfu New Materials Technology Co.,Ltd (688359.SS) Income Statement Analysis – Financial Results
I'rom Group Co., Ltd. (2372.T)
About I'rom Group Co., Ltd.
I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable diseases; and establishes and operates clinic malls. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.74B | 18.35B | 15.69B | 12.91B | 10.59B | 10.58B | 8.62B | 4.89B | 4.11B | 4.13B | 4.01B | 6.70B | 11.02B | 13.99B | 13.82B | 14.48B | 13.73B |
| Cost of Revenue | 10.24B | 9.29B | 8.45B | 8.48B | 6.33B | 6.52B | 5.11B | 3.09B | 2.99B | 3.31B | 2.94B | 4.60B | 8.39B | 10.13B | 9.93B | 10.17B | 9.74B |
| Gross Profit | 7.51B | 9.07B | 7.24B | 4.43B | 4.26B | 4.06B | 3.51B | 1.80B | 1.12B | 829.00M | 1.07B | 2.10B | 2.63B | 3.86B | 3.89B | 4.31B | 3.99B |
| Gross Profit Ratio | 42.31% | 49.40% | 46.14% | 34.32% | 40.22% | 38.33% | 40.73% | 36.85% | 27.25% | 20.05% | 26.68% | 31.35% | 23.86% | 27.58% | 28.15% | 29.79% | 29.05% |
| Research & Development | 682.00M | 859.00M | 582.00M | 135.00M | 133.00M | 170.00M | 107.00M | 128.00M | 124.00M | 166.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 498.00M | 178.00M | 176.00M | 230.00M | 171.00M | 186.00M | 152.00M | 455.00M | 459.00M | 459.00M | 458.00M | 425.00M | 626.00M | 360.00M | 419.00M | 407.00M | 422.00M |
| Selling & Marketing | 5.19B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.69B | 178.00M | 176.00M | 230.00M | 171.00M | 186.00M | 152.00M | 455.00M | 459.00M | 459.00M | 458.00M | 425.00M | 626.00M | 360.00M | 419.00M | 407.00M | 422.00M |
| Other Expenses | 1.00M | -132.00M | -212.00M | -63.00M | -108.00M | 18.00M | 25.00M | 50.00M | -305.00M | 91.00M | 95.00M | 127.00M | -1.21B | -28.00M | 36.00M | 79.00M | 271.00M |
| Operating Expenses | 6.37B | 5.42B | 4.47B | 3.36B | 3.05B | 2.83B | 2.46B | 920.00M | 912.00M | 914.00M | 1.09B | 1.23B | 2.12B | 1.99B | 2.18B | 2.22B | 1.98B |
| Cost & Expenses | 16.61B | 14.71B | 12.93B | 11.84B | 9.38B | 9.36B | 7.57B | 4.01B | 3.91B | 4.22B | 4.03B | 5.83B | 10.51B | 12.12B | 12.11B | 12.39B | 11.72B |
| Interest Income | 22.00M | 101.00M | 13.00M | 37.00M | 30.00M | 8.00M | 10.00M | 16.00M | 26.00M | 15.00M | 40.00M | 29.00M | 36.00M | 39.00M | 41.00M | 38.00M | 27.00M |
| Interest Expense | 178.00M | 146.00M | 103.00M | 78.00M | 74.00M | 51.00M | 43.00M | 25.00M | 11.00M | 4.00M | 0.00 | 8.00M | 95.00M | 117.00M | 140.00M | 111.00M | 97.00M |
| Depreciation & Amortization | 1.14B | 797.00M | 607.00M | 495.00M | 363.00M | 214.00M | 278.00M | 208.00M | 198.00M | 115.00M | 76.00M | 111.00M | 299.00M | 562.00M | 788.00M | 899.00M | 885.00M |
| EBITDA | 3.28B | 4.30B | 3.14B | 1.56B | 1.57B | 1.44B | 1.35B | 423.00M | -602.00M | -446.00M | -256.00M | 1.90B | 257.00M | 786.00M | 250.00M | -9.23B | -41.91M |
| EBITDA Ratio | 18.49% | 24.32% | 21.59% | 13.20% | 13.58% | 13.69% | 16.08% | 24.03% | 2.19% | 5.01% | 3.37% | 18.02% | -3.27% | 17.46% | 18.61% | 21.47% | 23.23% |
| Operating Income | 1.13B | 3.64B | 2.76B | 1.07B | 1.21B | 1.22B | 1.04B | 212.00M | -480.00M | -772.00M | -402.00M | 369.00M | -432.00M | 340.00M | -162.00M | 53.00M | -430.00M |
| Operating Income Ratio | 6.39% | 19.83% | 17.61% | 8.28% | 11.39% | 11.52% | 12.11% | 4.34% | -11.67% | -18.67% | -10.02% | 5.50% | -3.92% | 2.43% | -1.17% | 0.37% | -3.13% |
| Total Other Income/Expenses | 832.00M | -297.00M | -178.00M | 619.00M | -80.00M | -41.00M | 780.00M | 63.00M | -331.00M | 170.00M | 68.00M | 1.42B | 295.00M | -233.00M | -516.00M | -10.41B | -594.00M |
| Income Before Tax | 1.97B | 3.34B | 2.59B | 1.69B | 1.13B | 1.18B | 1.82B | 275.00M | -811.00M | -602.00M | -334.00M | 1.79B | -137.00M | 107.00M | -678.00M | -10.62B | -1.02B |
| Income Before Tax Ratio | 11.08% | 18.21% | 16.48% | 13.07% | 10.64% | 11.14% | 21.16% | 5.62% | -19.71% | -14.56% | -8.33% | 26.63% | -1.24% | 0.76% | -4.91% | -73.37% | -7.46% |
| Income Tax Expense | 551.00M | 789.00M | 630.00M | 311.00M | -109.00M | 278.00M | 231.00M | 79.00M | 74.00M | -1.00M | -38.00M | 34.00M | 215.00M | -108.00M | 48.00M | 286.00M | 164.00M |
| Net Income | 1.42B | 2.54B | 1.96B | 1.37B | 1.24B | 912.00M | 1.56B | 204.00M | -868.00M | -606.00M | -294.00M | 1.75B | -364.00M | 226.00M | -731.00M | -10.88B | -1.09B |
| Net Income Ratio | 7.98% | 13.85% | 12.50% | 10.64% | 11.67% | 8.62% | 18.07% | 4.17% | -21.10% | -14.66% | -7.33% | 26.12% | -3.30% | 1.62% | -5.29% | -75.18% | -7.94% |
| EPS | 116.87 | 210.19 | 162.45 | 114.25 | 105.80 | 78.24 | 135.32 | 18.77 | -81.79 | -59.08 | -30.75 | 187.25 | -38.92 | 24.18 | -78.17 | -1.16K | -116.56 |
| EPS Diluted | 116.87 | 210.02 | 162.12 | 113.93 | 104.26 | 75.75 | 132.13 | 18.72 | -81.79 | -59.08 | -30.75 | 187.25 | -38.92 | 24.18 | -78.17 | -1.16K | -116.56 |
| Weighted Avg Shares Out | 12.11M | 12.09M | 12.07M | 12.02M | 11.68M | 11.66M | 11.51M | 10.88M | 10.61M | 10.26M | 9.56M | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Weighted Avg Shares Out (Dil) | 12.11M | 12.10M | 12.10M | 12.05M | 11.85M | 12.04M | 11.79M | 10.90M | 10.61M | 10.26M | 9.56M | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
Source: https://incomestatements.info
Category: Stock Reports